What is the current price of PRFN.SW stock and why did it move today?

PRFN.SW stock trades at **CHF 0.0362** intraday. The move today reflects heavy volume (**2,937,350** shares), thin-market liquidity and speculative trades around Kinarus’s clinical pipeline, rather than a public earnings release.

What is Meyka AI’s view on PRFN.SW stock?

Meyka AI rates PRFN.SW **60.49/100 (Grade B, HOLD)** and projects a **CHF 0.0620** 12-month forecast. The outlook balances potential pipeline upside with funding and liquidity risks. Forecasts are projections, not guarantees.

How should traders approach PRFN.SW stock given today’s activity?

Traders should note wide spreads and high intraday volatility for PRFN.SW stock. Use scaled entries, confirm moves with volume, set strict stops, and avoid oversized positions because microcap liquidity can reverse quickly.

Where can I find more official information on Kinarus for PRFN.SW stock research?

For company facts and clinical updates visit Kinarus Therapeutics’ website at [Kinarus Therapeutics](https://www.kinarus.com). For market-level data see the Meyka stock page for PRFN.SW for real-time analytics and alerts at [Meyka PRFN.SW page](https://meyka.ai/stocks/PRFN.SW).

CH Stocks

PRFN.SW Kinarus Therapeutics (SIX) CHF0.0362 intraday 09 Feb 2026: volume spike

ByHuzaifa Zahoor February 9, 2026February 9, 2026

We see PRFN.SW stock trading at CHF 0.0362 intraday on SIX on 09 Feb 2026 after a -8.12% move from yesterday. Volume is heavy at 2,937,350 shares, more than three times the average, marking PRFN.SW as one of Switzerland’s most active tickers today. The move follows low recent price averages and continued clinical-stage news expectations for Kinarus Therapeutics Holding AG. We examine what drives the intraday swing, what the metrics show, and where traders may focus next.